MRM Technologies has spun off inflammatory bowel disease drug developer MRM Health with $15m from investors including strategic partner DuPont.

MRM Health was set up by Ghent spinout MRM Technologies to develop treatments based on the microbiome and has now concluded its first funding round backed by Qbic and VIB.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The University Technology Fund hopes to tap investment funds and development finance institutions to raise additional capital.

Proceeds from the Novo-backed series B round will be used to advance Spruce Biosciences' congenital adrenal hyperplasia candidate into phase 2 trials.

WuXi AppTec has co-led a $98m series D round for China-focused drug developer Canbridge Pharmaceuticals that also featured fellow corporate Tigermed.

The sickle cell disease drug developer, which is backed by Pfizer Ventures and Lundbeckfonden Ventures, has filed for an $86.3m IPO.

KKR's Gamma Biosciences platform has committed $54.1m in financing to a new subsidiary of Univercells, whose existing investors include Takeda.

Fonds de solidarité FTQ has officially invested $5m in the fourth fund of ULB's Theodorus, with Théo Risopoulos named as the first team member of a new Quebec office.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.